JP2022535064A5 - - Google Patents

Info

Publication number
JP2022535064A5
JP2022535064A5 JP2021571699A JP2021571699A JP2022535064A5 JP 2022535064 A5 JP2022535064 A5 JP 2022535064A5 JP 2021571699 A JP2021571699 A JP 2021571699A JP 2021571699 A JP2021571699 A JP 2021571699A JP 2022535064 A5 JP2022535064 A5 JP 2022535064A5
Authority
JP
Japan
Application number
JP2021571699A
Other languages
Japanese (ja)
Other versions
JPWO2020247301A5 (https=
JP2022535064A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/035511 external-priority patent/WO2020247301A1/en
Publication of JP2022535064A publication Critical patent/JP2022535064A/ja
Publication of JP2022535064A5 publication Critical patent/JP2022535064A5/ja
Publication of JPWO2020247301A5 publication Critical patent/JPWO2020247301A5/ja
Pending legal-status Critical Current

Links

JP2021571699A 2019-06-05 2020-06-01 肺炎レンサ球菌血清型29から保護する免疫原性組成物で患者を治療する方法 Pending JP2022535064A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962857534P 2019-06-05 2019-06-05
US62/857,534 2019-06-05
PCT/US2020/035511 WO2020247301A1 (en) 2019-06-05 2020-06-01 Methods of treating patients with an immunogenic composition that protects against s. pneumoniae serotype 29

Publications (3)

Publication Number Publication Date
JP2022535064A JP2022535064A (ja) 2022-08-04
JP2022535064A5 true JP2022535064A5 (https=) 2023-06-20
JPWO2020247301A5 JPWO2020247301A5 (https=) 2023-06-20

Family

ID=73653320

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021571699A Pending JP2022535064A (ja) 2019-06-05 2020-06-01 肺炎レンサ球菌血清型29から保護する免疫原性組成物で患者を治療する方法

Country Status (10)

Country Link
US (1) US20220218812A1 (https=)
EP (1) EP3980050A4 (https=)
JP (1) JP2022535064A (https=)
KR (1) KR20220016964A (https=)
CN (1) CN114025784A (https=)
AU (1) AU2020289048A1 (https=)
BR (1) BR112021024491A8 (https=)
CA (1) CA3142697A1 (https=)
MX (1) MX2021014948A (https=)
WO (1) WO2020247301A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110225764A (zh) 2017-01-31 2019-09-10 默沙东公司 制备多糖-蛋白缀合物的方法
CA3050120A1 (en) 2017-02-24 2018-08-30 Merck Sharp & Dohme Corp. Enhancing immunogenicity of streptococcus pneumoniae polysaccharide-protein conjugates
CN111065387B (zh) 2017-09-07 2023-08-25 默沙东有限责任公司 肺炎球菌多糖及其在免疫原性多糖-载体蛋白缀合物中的用途
WO2019050813A1 (en) 2017-09-07 2019-03-14 Merck Sharp & Dohme Corp. ANTI-PNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN IMMUNOGENIC CONJUGATES POLYSACCHARIDE-PROTEIN CARRIER
TWI725359B (zh) 2017-12-06 2021-04-21 美商默沙東藥廠 包含肺炎鏈球菌多醣-蛋白結合物之組合物及其使用方法
US12144855B2 (en) 2018-04-30 2024-11-19 Merck Sharp & Dohme Llc Methods for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugates from lyospheres
JP7397000B2 (ja) 2018-04-30 2023-12-12 メルク・シャープ・アンド・ドーム・エルエルシー 凍結乾燥変異ジフテリア毒素のジメチルスルホキシド中均一溶液を提供する方法
EP3787673A4 (en) 2018-04-30 2022-04-27 Merck Sharp & Dohme Corp. Methods for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugates
GEAP202415690A (en) 2018-12-19 2024-01-10 Merck Sharp & Dohme Llc Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2311976A1 (en) * 2009-10-19 2011-04-20 Azienda Ospedaliero-Universitaria Meyer Method for Streptococcus Pneumoniae diagnosis and serotyping
TW201136603A (en) * 2010-02-09 2011-11-01 Merck Sharp & Amp Dohme Corp 15-valent pneumococcal polysaccharide-protein conjugate vaccine composition
EP4488286A3 (en) * 2016-03-31 2025-04-02 Pogona, Llc Saccharide-polypeptide conjugate compositions and methods of use thereof
BR112019006278A2 (pt) * 2016-09-30 2019-07-02 Biological E Limited composições de vacina pneumocócica multivalente que compreendem conjugados de polissacarídeo-proteína
ES3024474T3 (en) * 2016-12-30 2025-06-04 Vaxcyte Inc Polypeptide-antigen conjugates with non-natural amino acids

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)